Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02876003
Title Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors GenSpera, Inc
Indications

glioblastoma

Therapies

Mipsagargin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.